Related Experiment Video
Updated: May 8, 2026
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Dissecting cancer heterogeneity--an unsupervised classification approach.
Xin Wang1, Florian Markowetz, Felipe De Sousa E Melo
1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
The International Journal of Biochemistry & Cell Biology
|September 6, 2013
Summary
Gene-expression classification reveals distinct cancer subtypes, moving beyond single-disease views. Understanding these molecular subtypes is crucial for personalized medicine and targeted cancer drug development.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- Traditional cancer classification is evolving with gene-expression data.
- Many cancers comprise multiple distinct molecular subtypes, not a single disease entity.
Purpose of the Study:
- To review unsupervised classification studies of common malignancies.
- To summarize bioinformatic workflows and methods, focusing on consensus clustering and classification.
Main Methods:
- Review of recent unsupervised gene-expression-based classification studies.
- Focus on common bioinformatic workflows and statistical tools.
- Explanation of consensus clustering and classification principles.
Main Results:
- Gene-expression studies reveal significant cancer heterogeneity.
- A common bioinformatic workflow is prevalent, with variations in statistical tools.
- Consensus clustering is a key method for subtype identification.
Conclusions:
- Understanding cancer heterogeneity through molecular subtypes is critical.
- These methods impact patient stratification and development of subtype-specific cancer drugs.
- Enhanced understanding of these bioinformatic approaches is needed for the biomedical community.
